Literature DB >> 19404204

Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version.

Mercedes Vergara1, Antònia Montserrat, Francesc Casellas, Michael Maudsley, Olga Gallardo, Elena Ricart, Xavier Calvet.   

Abstract

BACKGROUND: The Work Productivity and Activity Impairment questionnaire has only been partially validated in Crohn's disease.
OBJECTIVE: To test the Work Productivity and Activity Impairment questionnaire for use in Crohn's disease patients.
METHODS: A validated Spanish translation of the test was assessed. 'Discriminant validity' was evaluated by comparing Work Productivity and Activity Impairment scores in Crohn's disease patients with active versus inactive disease, and in patients versus healthy controls. 'Convergent validity' was tested comparing Work Productivity and Activity Impairment questionnaire with quality of life, Crohn's disease activity index and a debriefing questionnaire. 'Reproducibility' of repeated tests was evaluated by comparing two Work Productivity and Activity Impairment measures obtained 2 weeks apart in stable patients. 'Responsiveness' was determined by comparing Work Productivity and Activity Impairment values in the same patients during a flare-up of Crohn's disease and during remission. The Wilcoxon test for paired data and the Mann-Whitney U test for unpaired data were used for comparisons.
RESULTS: One hundred and six patients were included in the various steps of the analysis. All Work Productivity and Activity Impairment parameters showed adequate discriminant and convergent validity and responsiveness. The test's reproducibility was also adequate, except for the evaluation of presenteeism (the impairment of productivity while working).
CONCLUSION: The Spanish Work Productivity and Activity Impairment questionnaire is a valid and reliable measurement of work impairment in Crohn's disease. Unexpectedly, the test did not present satisfactory reproducibility for the evaluation of presenteeism. The reliability of this last finding should be evaluated in further studies.

Entities:  

Mesh:

Year:  2009        PMID: 19404204     DOI: 10.1097/MEG.0b013e32830f4c9e

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity.

Authors:  Jessica Fourquet; Lorna Báez; Michelle Figueroa; R Iván Iriarte; Idhaliz Flores
Journal:  Fertil Steril       Date:  2011-05-31       Impact factor: 7.329

2.  Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial.

Authors:  María Chaparro; María G Donday; Manuel Barreiro-de Acosta; Eugeni Domènech; María Esteve; Valle García-Sánchez; Pilar Nos; Julián Panés; Concepción Martínez; Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2019-09-13       Impact factor: 4.409

3.  Validation of a self-reported work disability questionnaire for ulcerative colitis.

Authors:  Alexis Ramos; Mercedes Vergara; Luigi Melcarne; Beatriz Sicilia; Fernando Gomollón; Xavier Calvet
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

4.  Protocol of a multicentric prospective cohort study for the VALIDation of the IBD-disk instrument for assessing disability in inflammatory bowel diseases: the VALIDate study.

Authors:  C Le Berre; A Bourreille; M Flamant; G Bouguen; L Siproudhis; M Dewitte; N Dib; E Cesbron-Metivier; T Goronflot; M Hanf; P-A Gourraud; E Kerdreux; A Poinas; C Trang-Poisson
Journal:  BMC Gastroenterol       Date:  2020-04-16       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.